Clinical Trial: Intravenous Fish Oil Emulsion in Critically Ill Patients With High Inflammatory Status.

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883447) titled 'Intravenous Fish Oil Emulsion in Critically Ill Patients With High Inflammatory Status.' on Sept. 22.

Brief Summary: Critically ill patients can develop high levels of inflammation, which may contribute to organ damage, muscle loss, and difficulty recovering physical function. Fish oil contains omega-3 fatty acids that may help reduce inflammation. However, the most suitable dose of fish oil given intravenously (directly into a vein) in critically ill patients with high levels of inflammation is uncertain.

The FOiL-INFLAMe trial is a phase II study comparing two doses of intravenous fish oil with usual care. Its main purpose is to ...